Crinetics Pharmaceuticals EBIT 2017-2024 | CRNX

Crinetics Pharmaceuticals EBIT for the quarter ending September 30, 2024 was $-0.088B, a 48.87% increase year-over-year.

  • Crinetics Pharmaceuticals 2023 EBIT was -0.223B, a 32.6% increase from 2022.
  • Crinetics Pharmaceuticals 2022 EBIT was -0.168B, a 55.88% increase from 2021.
  • Crinetics Pharmaceuticals 2021 EBIT was -0.108B, a 43.69% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Crinetics Pharmaceuticals EBIT 2017-2024 | CRNX

  • Crinetics Pharmaceuticals 2023 EBIT was -0.223B, a 32.6% increase from 2022.
  • Crinetics Pharmaceuticals 2022 EBIT was -0.168B, a 55.88% increase from 2021.
  • Crinetics Pharmaceuticals 2021 EBIT was -0.108B, a 43.69% increase from 2020.

EBIT can be defined as earnings before interest and taxes.